The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases

Immunoglobulin therapy represents a lifesaving intervention for many patients with primary immunodeficiency (PID). Antibody defects represent approximately half of the well-known PIDs requiring immunoglobulin replacement therapy. Following immunoglobulin therapy in PID patients, protection against s...

Full description

Saved in:
Bibliographic Details
Published inEndocrine, metabolic & immune disorders drug targets Vol. 16; no. 2; p. 80
Main Authors Azizi, Gholamreza, Abolhassani, Hassan, Asgardoon, Mohammad Hosein, Rahnavard, Javad, Dizaji, Majid Zaki, Yazdani, Reza, Mohammadi, Javad, Aghamohammadi, Asghar
Format Journal Article
LanguageEnglish
Published United Arab Emirates 01.01.2016
Subjects
primary immunodeficiency diseases
infection
Immunoglobulin
primary antibody deficiency
Online AccessGet more information

Cover

More Information
Summary:Immunoglobulin therapy represents a lifesaving intervention for many patients with primary immunodeficiency (PID). Antibody defects represent approximately half of the well-known PIDs requiring immunoglobulin replacement therapy. Following immunoglobulin therapy in PID patients, protection against serious upper and lower respiratory tract infections and pulmonary function improves which leads to an increase in the quality of life of these patients. Successful treatment of PID patients depends on the type of immunodeficiency, regular monitoring of the patient, comorbidities of the patient, and the availability of the products.
ISSN:2212-3873
DOI:10.2174/1871530316666160724214418